When to Begin Gluteal Intramuscular Injections in Children
The gluteal region (specifically the ventrogluteal site) can be used for intramuscular injections in children as young as 12 months of age, while the dorsogluteal site should be avoided entirely in all children regardless of age due to the risk of sciatic nerve injury.
Site Selection by Age
Infants and Young Children (Birth to 3 Years)
- Preferred site: Anterolateral thigh for all children under 3 years 1, 2, 3, 2, 4
- The anterolateral thigh remains the safest and most recommended site for infants and toddlers
- Ventrogluteal site can be considered starting at 12 months based on ultrasound evidence showing adequate muscle development 5
Children 3 Years and Older
- Deltoid muscle becomes appropriate for older children with adequate muscle mass 1, 3, 2
- Ventrogluteal site is fully appropriate and increasingly advantageous as the child grows 5, 6
- The ventrogluteal site shows thicker muscle and less subcutaneous tissue than the anterolateral thigh in children 12-36 months old 5
Critical Safety Considerations
Never Use the Dorsogluteal Site in Children
The dorsogluteal (upper outer buttock) site is contraindicated in children of all ages 7, 8, 9. This is a common and dangerous error:
- Risk of sciatic nerve injury leading to lower limb palsy or paralytic drop foot 8
- Injury can occur from direct trauma or caustic effects of injected medications
- Complications can happen despite meticulous technique 9
- One survey found 21% of practitioners incorrectly selected this site for pediatric patients 7
Ventrogluteal Site Advantages
When the gluteal region is appropriate (≥12 months), the ventrogluteal site is superior to dorsogluteal:
- Located at the posterior lateral aspect of the upper buttocks 10
- Adequate muscle development even in infants 1-12 months (8.17 mm muscle thickness) 5
- In children 25-36 months: 19.62 mm muscle thickness vs. 18.81 mm in anterolateral thigh 5
- Significantly less pain and fear compared to vastus lateralis in children 4-6 years 6
- Lower subcutaneous tissue thickness reduces risk of subcutaneous injection 5
Practical Implementation Algorithm
For children requiring IM injection:
- Age <12 months: Use anterolateral thigh exclusively
- Age 12-36 months:
- First choice: Anterolateral thigh
- Alternative: Ventrogluteal site (if adequate muscle mass confirmed)
- Age >3 years:
- Deltoid (if adequate muscle mass)
- Ventrogluteal site
- Anterolateral thigh
- All ages: NEVER use dorsogluteal site
Technical Specifications
Needle Length and Technique
- Children <12 months: 7/8 to 1 inch needle for anterolateral thigh 3
- Children with adequate deltoid mass: 7/8 to 1.25 inches 3
- Avoid bony prominences by 1-2 adult fingerbreadths 10
- Maximum volume per site: 1 mL (exceeding this increases complication risk) 7
Common Pitfalls to Avoid
- Using 1.5-inch needles in children <24 months increases risk of complications 7
- Splitting 0.5 mL prefilled syringes into two 0.25 mL doses is contraindicated due to sterility concerns 11, 4
- Confusing "buttock" with dorsogluteal site - guidelines referring to "buttock" mean the ventrogluteal/posterior lateral aspect, not the dorsogluteal area 10
The evidence strongly supports that while the anterolateral thigh remains the gold standard for young children, the ventrogluteal site provides a safe gluteal alternative starting around 12 months of age, with increasing advantages as children grow older. The dorsogluteal site has no place in pediatric practice at any age.